Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Raubitschek

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Hybridoma|January 1, 1984
Production of human monoclonal antibody in mouse ascitesK E Truitt, J W Larrick, A A Raubitschek, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodiesP Ferroni, D E Milenic, M Roselli, et al.
The International Journal of Biological Markers|October 1, 1990
Potential for artifacts in monitoring for the detection of tumor associated antigens (TAG-72 and CEA) in serum from patients undergoing MAb-based diagnostic and therapeutic protocolsP Ferroni, D E Milenic, M Roselli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 1999
A radionuclide therapy treatment planning and dose estimation systemA Liu, L E Williams, G Lopatin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1995
Dosimetric considerations in treating mediastinal disease with mantle fields: characterization of the dose under mantle blocksR W Miller, J van de Geijn, A A Raubitschek, et al.
Bioconjugate Chemistry|April 21, 2001
Metabolism and renal clearance of 111In-labeled DOTA-conjugated antibody fragmentsS W Tsai, L Li, L E Williams, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenograftsM Roselli, J Schlom, O A Gansow, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1991
An isocentric chair for the simulation and treatment of radiation therapy patientsR W Miller, A A Raubitschek, F S Harrington, et al.
Bioconjugate Chemistry|January 17, 2002
Vinyl sulfone bifunctional derivatives of DOTA allow sulfhydryl- or amino-directed coupling to antibodies. Conjugates retain immunoreactivity and have similar biodistributionsLin Li, Shih-Wa Tsai, Anne-Line Anderson, et al.
Bioconjugate Chemistry|May 23, 2000
Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5S W Tsai, Y Sun, L E Williams, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Hybridoma|January 1, 1984
Production of human monoclonal antibody in mouse ascitesK E Truitt, J W Larrick, A A Raubitschek, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodiesP Ferroni, D E Milenic, M Roselli, et al.
The International Journal of Biological Markers|October 1, 1990
Potential for artifacts in monitoring for the detection of tumor associated antigens (TAG-72 and CEA) in serum from patients undergoing MAb-based diagnostic and therapeutic protocolsP Ferroni, D E Milenic, M Roselli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 1999
A radionuclide therapy treatment planning and dose estimation systemA Liu, L E Williams, G Lopatin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1995
Dosimetric considerations in treating mediastinal disease with mantle fields: characterization of the dose under mantle blocksR W Miller, J van de Geijn, A A Raubitschek, et al.
Bioconjugate Chemistry|April 21, 2001
Metabolism and renal clearance of 111In-labeled DOTA-conjugated antibody fragmentsS W Tsai, L Li, L E Williams, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenograftsM Roselli, J Schlom, O A Gansow, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1991
An isocentric chair for the simulation and treatment of radiation therapy patientsR W Miller, A A Raubitschek, F S Harrington, et al.
Bioconjugate Chemistry|January 17, 2002
Vinyl sulfone bifunctional derivatives of DOTA allow sulfhydryl- or amino-directed coupling to antibodies. Conjugates retain immunoreactivity and have similar biodistributionsLin Li, Shih-Wa Tsai, Anne-Line Anderson, et al.
Bioconjugate Chemistry|May 23, 2000
Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5S W Tsai, Y Sun, L E Williams, et al.
Pageof 9